The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer

Author:              

Publisher: Spandidos Publications

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.45, Iss.4, 2014-01, pp. : 1658-1672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content